Qin Gui Huo Luo Oral Liquid Attenuates Blood–Brain Barrier Dysfunction after Cerebral Ischemia–Reperfusion Injury in Mice via the Regulation of the PI3K/AKT/FOXO3A Signaling Pathway
Biological and Pharmaceutical Bulletin · 2025
DOI: 10.1248/bpb.b25-00455 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biological and Pharmaceutical Bulletin, 2025. Verfasst von Xueyu Ling und 4 weiteren Autor:innen. Beteiligte Einrichtung: Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory, Harbin 150088, China. Hauptthemen laut MEDLINE: Blood-Brain Barrier, Reperfusion Injury, Drugs, Chinese Herbal, Neuroprotective Agents. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Harbin Pharmaceutical Group Shiyitang Pharmaceutical Factory, Harbin 150088, China.
- State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of TCM Evaluation and Translational Research, Department of Pharmacology of Chinese Materia Medica, School of Traditional Chinese Pharmacy, China Pharmac…
Zitieren
APA
Ling, X., Bao, L., Xu, Y., Gong, S., & Kou, J. (2025). Qin Gui Huo Luo Oral Liquid Attenuates Blood–Brain Barrier Dysfunction after Cerebral Ischemia–Reperfusion Injury in Mice via the Regulation of the PI3K/AKT/FOXO3A Signaling Pathway. Biological and Pharmaceutical Bulletin. https://doi.org/10.1248/bpb.b25-00455
Vancouver
Ling X, Bao L, Xu Y, Gong S, Kou J. Qin Gui Huo Luo Oral Liquid Attenuates Blood–Brain Barrier Dysfunction after Cerebral Ischemia–Reperfusion Injury in Mice via the Regulation of the PI3K/AKT/FOXO3A Signaling Pathway. Biological and Pharmaceutical Bulletin. 2025. doi:10.1248/bpb.b25-00455
BibTeX
@article{Ling2025,
author = {Ling, Xueyu and Bao, Liangying and Xu, Yuanhao and Gong, Shuaishuai and Kou, Junping},
title = {Qin Gui Huo Luo Oral Liquid Attenuates Blood–Brain Barrier Dysfunction after Cerebral Ischemia–Reperfusion Injury in Mice via the Regulation of the PI3K/AKT/FOXO3A Signaling Pathway},
journal = {Biological and Pharmaceutical Bulletin},
year = {2025},
doi = {10.1248/bpb.b25-00455}
}
EUVIMED